Greater Glasgow and Clyde Medicines

 Oral Proton Pump Inhibitors

• Proton Pump Inhibitors (PPIs) are one of the most commonly prescribed classes of drug
• PPIs are an effective treatment when used appropriately
• PPIs should only be prescribed where there is a clear indication
• PPIs are usually well tolerated
• Recent evidence suggests that PPIs may have potentially serious adverse effects such as fractures, hypomagnesaemia, subacute cutaneous lupus erythematosus, pneumonia and Clostridium difficile infection

Greater Glasgow and Clyde Area Drug and Therapeutics Committee met on Monday 14th December. This blog details the Formulary decisions made at that meeting.

Management of Urinary Incontinence and Overactive Bladder

Archived February 2022.

Greater Glasgow and Clyde Area Drug and Therapeutics Committee met on Monday 19th October. This blog details the Formulary decisions made at that meeting.

ADTC met on Monday 17th August. This blog entry contains all the Formulary decisions from that meeting.

ADTC met on Monday 8th January. This blog entry contains all the Formulary decisions from that meeting

ADTC met on 20th April 2015. This blog entry contains all the Formulary decisions from that meeting

ADTC met on 15th Feb - this blog entry contains all the Formulary decisions from that meeting

Management of Staphylococcus aureus bacteraemia (SAB) in NHSGG&C